Rigel Pharmaceuticals (RIGL) Short Interest Ratio & Short Volume $17.07 -1.38 (-7.48%) (As of 04:00 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Rigel Pharmaceuticals Short Interest DataRigel Pharmaceuticals (RIGL) has a short interest of 470,900 shares, representing 2.73% of the float (the number of shares available for trading by the public). This marks a 1.77% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.2, indicating that it would take 2.2 days of the average trading volume of 165,543 shares to cover all short positions.Current Short Interest470,900 sharesPrevious Short Interest462,700 sharesChange Vs. Previous Month+1.77%Dollar Volume Sold Short$13.00 millionShort Interest Ratio2.2 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares17,615,000 sharesFloat Size17,270,000 sharesShort Percent of Float2.73%Today's Trading Volume153,668 sharesAverage Trading Volume165,543 sharesToday's Volume Vs. Average93% Short Selling Rigel Pharmaceuticals? Sign up to receive the latest short interest report for Rigel Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRIGL Short Interest Over TimeRIGL Days to Cover Over TimeRIGL Percentage of Float Shorted Over Time Ad Brownstone ResearchDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Rigel Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024470,900 shares $13.00 million +1.8%2.7%2.2 $27.61 11/15/2024462,700 shares $11.15 million -30.0%2.7%2.3 $24.10 10/31/2024661,200 shares $9.01 million -7.9%3.8%3.9 $13.63 10/15/2024718,000 shares $10.99 million +54.9%4.2%5.3 $15.30 9/30/2024463,500 shares $7.50 million -7.4%2.7%3.3 $16.18 9/15/2024500,500 shares $6.86 million -14.5%2.9%2.9 $13.70 Get the Latest News and Ratings for RIGL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rigel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024585,300 shares $7.87 million +3.7%3.4%3.4 $13.44 8/15/2024564,500 shares $7.04 million +2.3%3.3%3.2 $12.47 7/31/2024552,100 shares $5.84 million -9.9%3.2%3.1 $10.58 7/15/2024612,900 shares $6.49 million -5.5%3.6%3.1 $10.59 6/30/2024648,200 shares $5.33 million -86.8%3.8%3.1 $8.22 6/15/20244,900,000 shares $46.70 million -7.2%N/A3.2 $9.53 5/31/20245,280,000 shares $5.16 million -6.4%N/A3.6 $0.98 5/15/20245,640,000 shares $5.47 million -0.5%N/A3.7 $0.97 4/30/20245,670,000 shares $5.95 million +9.7%N/A3.8 $1.05 4/15/20245,170,000 shares $5.95 million +3.2%N/A3.7 $1.15 3/31/20245,010,000 shares $7.41 million +1.4%N/A4 $1.48 3/15/20244,940,000 shares $6.72 million +32.1%N/A4.5 $1.36 2/29/20243,740,000 shares $5.68 million +6.9%N/A3.5 $1.52 2/15/20243,500,000 shares $4.27 million +2.3%N/A3.1 $1.22 1/31/20243,420,000 shares $4.00 million No ChangeN/A3.3 $1.17 1/15/20243,420,000 shares $4.55 million -5.3%N/A2.8 $1.33 12/31/20233,610,000 shares $5.23 million -0.6%N/A3 $1.45 12/15/20233,630,000 shares $4.68 million -4.0%N/A3.1 $1.29 11/30/20233,780,000 shares $4.31 million -1.3%N/A3.2 $1.14 11/15/20233,830,000 shares $3.04 million +5.5%N/A4 $0.79 10/31/20233,630,000 shares $2.93 million -4.0%N/A3.5 $0.81 10/15/20233,780,000 shares $3.55 million +1.9%N/A3.3 $0.94 9/30/20233,710,000 shares $4.01 million +3.6%N/A3.7 $1.08 9/15/20233,580,000 shares $4.08 million -6.3%N/A3.1 $1.14 8/31/20233,820,000 shares $4.35 million +2.7%N/A3.1 $1.14 8/15/20233,720,000 shares $4.39 million -7.7%N/A2.5 $1.18 7/31/20234,030,000 shares $5.56 million +4.7%N/A2 $1.38 7/15/20233,850,000 shares $4.85 million +0.5%N/A1.8 $1.26 6/30/20233,830,000 shares $4.94 million -39.7%N/A1.8 $1.29 6/15/20236,350,000 shares $10.48 million -15.5%N/A2.8 $1.65 5/31/20237,510,000 shares $10.51 million -7.3%N/A2.9 $1.40 5/15/20238,100,000 shares $10.85 million -4.8%N/A2.6 $1.34 4/30/20238,510,000 shares $9.62 million +0.5%N/A3.2 $1.13 4/15/20238,470,000 shares $10.42 million +1.6%N/A2.9 $1.23Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 3/31/20238,340,000 shares $11.01 million -1.1%N/A2.7 $1.32 3/15/20238,430,000 shares $14.16 million +10.2%N/A2.6 $1.68 2/28/20237,650,000 shares $11.55 million +12.5%N/A2 $1.51 2/15/20236,800,000 shares $11.02 million +13.7%N/A1.6 $1.62 1/31/20235,980,000 shares $9.81 million +6.0%N/A1.5 $1.64 1/15/20235,640,000 shares $9.98 million +5.0%N/A1.5 $1.77 12/30/20225,370,000 shares $8.06 million -15.8%N/A1.4 $1.50 12/15/20226,380,000 shares $8.10 million +57.5%N/A1.8 $1.27 11/30/20224,050,000 shares $2.72 million -26.5%N/A1 $0.67 11/15/20225,510,000 shares $4.14 million -7.6%N/A2 $0.75 10/31/20225,960,000 shares $4.34 million -16.9%N/A1.9 $0.73 10/15/20227,170,000 shares $5.82 million -6.0%N/A2 $0.81 9/30/20227,630,000 shares $9.00 million -30.3%N/A2 $1.18 9/15/202210,950,000 shares $14.45 million +16.2%N/A2.6 $1.32 8/31/20229,420,000 shares $13.38 million +0.3%N/A1.6 $1.42 8/15/20229,390,000 shares $14.65 million -6.4%N/A1.4 $1.56 7/31/202210,030,000 shares $11.94 million -4.0%6.3%1.6 $1.19 7/15/202210,450,000 shares $13.69 million -9.5%6.6%1.8 $1.31 6/30/202211,550,000 shares $13.05 million +62.2%7.2%2.1 $1.13 6/15/20227,120,000 shares $5.80 million +1.9%4.5%1.4 $0.81 5/31/20226,990,000 shares $12.65 million +4.5%N/A2 $1.81 5/15/20226,690,000 shares $13.11 million +0.9%N/A3.4 $1.96 4/30/20226,630,000 shares $15.65 million -24.5%N/A3.5 $2.36 4/15/20228,780,000 shares $26.08 million -12.1%N/A4.6 $2.97 3/31/20229,990,000 shares $29.87 million -22.3%N/A5.1 $2.99 3/15/202212,850,000 shares $37.14 million -10.8%N/A6.6 $2.89 2/28/202214,410,000 shares $36.17 million +3.2%8.5%8.1 $2.51 2/15/202213,960,000 shares $36.44 million -11.1%8.2%8.5 $2.61 1/31/202215,710,000 shares $40.22 million +1.5%9.2%9.4 $2.56 1/15/202215,480,000 shares $37.46 million +5.0%N/A9.4 $2.42 12/31/202114,750,000 shares $39.09 million -4.2%N/A9.7 $2.65 12/15/202115,390,000 shares $38.32 million +2.1%N/A10.8 $2.49 11/30/202115,070,000 shares $40.24 million -6.4%N/A11.2 $2.67 11/15/202116,100,000 shares $49.11 million -6.3%N/A12.2 $3.05 10/29/202117,180,000 shares $57.72 million +0.2%N/A13.1 $3.36 10/15/202117,140,000 shares $57.93 million -0.1%N/A12.2 $3.38 9/30/202117,160,000 shares $62.29 million -8.0%N/A12.2 $3.63 9/15/202118,660,000 shares $71.65 million -3.9%N/A12.4 $3.84 8/31/202119,410,000 shares $73.76 million -6.6%N/A11.7 $3.80 8/13/202120,780,000 shares $77.30 million +0.2%N/A11.7 $3.72 7/30/202120,730,000 shares $82.92 million -0.5%N/A10.6 $4.00 7/15/202120,830,000 shares $85.19 million -3.6%12.3%10.7 $4.09 6/30/202121,600,000 shares $93.74 million -11.0%12.7%8.6 $4.34 6/15/202124,280,000 shares $103.43 million +3.5%14.3%9.3 $4.26 5/28/202123,460,000 shares $87.27 million -1.9%13.8%8.9 $3.72 5/14/202123,920,000 shares $86.59 million +6.4%N/A7.8 $3.62 4/30/202122,480,000 shares $83.18 million -3.7%N/A6.2 $3.70 4/15/202123,340,000 shares $87.06 million +6.0%N/A5.8 $3.73 3/31/202122,030,000 shares $74.90 million +30.6%N/A5.9 $3.40 3/15/202116,870,000 shares $71.36 million +0.4%N/A4.4 $4.23Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 2/26/202116,810,000 shares $69.59 million -13.2%N/A4.4 $4.14 2/12/202119,360,000 shares $87.89 million -7.7%N/A5.6 $4.54 1/29/202120,970,000 shares $72.98 million -1.8%N/A7.2 $3.48 1/15/202121,360,000 shares $81.38 million -1.3%N/A8.4 $3.81 12/31/202021,650,000 shares $78.37 million -4.2%N/A9 $3.62 12/15/202022,600,000 shares $73.79 million -0.8%N/A9.3 $3.27 11/30/202022,780,000 shares $70.85 million -2.9%N/A9 $3.11 11/15/202023,460,000 shares $64.52 million -3.9%N/A9.1 $2.75 10/30/202024,420,000 shares $61.54 million +18.0%N/A9.1 $2.52 10/15/202020,700,000 shares $54.44 million +6.4%12.6%6.7 $2.63 9/30/202019,460,000 shares $46.70 million +96.0%11.8%2.4 $2.40 9/15/20209,930,000 shares $24.53 million +0.4%6.0%1.2 $2.47 8/31/20209,890,000 shares $24.63 million -0.3%6.0%1.3 $2.49 8/14/20209,920,000 shares $24.11 million +15.8%6.0%1.3 $2.43 7/31/20208,570,000 shares $19.71 million -44.1%5.2%1.1 $2.30 7/15/202015,320,000 shares $50.25 million +0.9%9.4%2.2 $3.28 6/30/202015,190,000 shares $27.34 million +3.9%9.3%8.3 $1.80 6/15/202014,620,000 shares $27.19 million -0.5%9.0%8.9 $1.86 5/29/202014,700,000 shares $29.84 million -0.3%9.0%9.6 $2.03 5/15/202014,740,000 shares $26.02 million +1.2%9.0%9.6 $1.77 4/30/202014,560,000 shares $26.50 million -4.6%8.8%10 $1.82 4/15/202015,260,000 shares $25.48 million +0.6%9.3%11.2 $1.67 3/31/202015,170,000 shares $23.67 million -0.4%9.2%10 $1.56 3/13/202015,229,200 shares $26.96 million -0.9%9.2%10.7 $1.77 2/28/202015,370,000 shares $21.98 million -1.8%9.3%9.9 $1.43 2/14/202015,650,000 shares $31.30 million +2.3%9.6%10.1 $2.00 1/31/202015,300,000 shares $33.20 million +42.6%9.3%9.7 $2.17 1/15/202010,730,000 shares $24.68 million -3.1%6.6%6.5 $2.30 12/31/201911,070,000 shares $27.90 million -6.5%6.8%7.3 $2.52 RIGL Short Interest - Frequently Asked Questions What is Rigel Pharmaceuticals' current short interest? Short interest is the volume of Rigel Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 470,900 shares of RIGL short. 2.73% of Rigel Pharmaceuticals' shares are currently sold short. Learn More on Rigel Pharmaceuticals' current short interest. What is a good short interest ratio for Rigel Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RIGL shares currently have a short interest ratio of 2.0. Learn More on Rigel Pharmaceuticals's short interest ratio. What is a good short interest percentage for Rigel Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.73% of Rigel Pharmaceuticals' floating shares are currently sold short. Is Rigel Pharmaceuticals' short interest increasing or decreasing? Rigel Pharmaceuticals saw a increase in short interest in November. As of November 30th, there was short interest totaling 470,900 shares, an increase of 1.8% from the previous total of 462,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Rigel Pharmaceuticals' float size? Rigel Pharmaceuticals currently has issued a total of 17,615,000 shares. Some of Rigel Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Rigel Pharmaceuticals currently has a public float of 17,270,000 shares. How does Rigel Pharmaceuticals' short interest compare to its competitors? 2.73% of Rigel Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Rigel Pharmaceuticals: Myriad Genetics, Inc. (3.72%), Innoviva, Inc. (17.34%), OPKO Health, Inc. (31.02%), Ironwood Pharmaceuticals, Inc. (7.20%), Sangamo Therapeutics, Inc. (7.17%), Emergent BioSolutions Inc. (13.32%), Codexis, Inc. (2.11%), XOMA Co. (0.96%), Vanda Pharmaceuticals Inc. (5.60%), Verastem, Inc. (5.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Rigel Pharmaceuticals stock? Short selling RIGL is an investing strategy that aims to generate trading profit from Rigel Pharmaceuticals as its price is falling. RIGL shares are trading down $0.69 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rigel Pharmaceuticals? A short squeeze for Rigel Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RIGL, which in turn drives the price of the stock up even further. How often is Rigel Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RIGL, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Myriad Genetics Short Interest Innoviva Short Interest OPKO Health Short Interest Ironwood Pharmaceuticals Short Interest Sangamo Therapeutics Short Interest Emergent BioSolutions Short Interest Codexis Short Interest XOMA Short Interest Vanda Pharmaceuticals Short Interest Verastem Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RIGL) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rigel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rigel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RIGL Stock Alerts